scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Glenmark Pharmaceuticals Ltd

Feedback
Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd (GLENMARK) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 481,433
Mar 03, 2025 15:52 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹1,313.20
₹34.25 (2.68%)
₹1277.3 Low
Today’s Performance
₹1318.75 High
₹883 Low
52 Week’s Performance
₹1830.95 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 2.68%
  • 1 Week -1.68%
  • 1 Month -8.59%
  • 3 Months -14.46%
  • 6 Months -25.10%
  • 1 Year 40.36%
  • 3 Years 41.81%
  • 5 Years 35.74%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 0.97
  • 52-Week Low (₹) 883.00
  • 52-Week High (₹) 1,830.95
  • Price-to-Book (X)* 4.27
  • Dividend Yield (%) 0.20
  • Price-to-Earnings (P/E) (X)* -205.26
  • Earnings Per Share (₹) -6.23
  • Sector Price Earning (X)* 31.64
  • Market Cap (₹ Cr.)* 36,090.45
  • * Vaues as of last close price

COMPETITORS

BT TV

Market Masters: A Balasubramanian | Expert Insights On Market Trends, Investments, SIPs 25:10 Market Masters: A Balasubramanian | Expert Insights On Market Trends, Investments, SIPs
Cals Refineries Case | FIR Order Against Madhabi Puri Buch | SEBI, BSE Move To Bombay High Court 2:22 Cals Refineries Case | FIR Order Against Madhabi Puri Buch | SEBI, BSE Move To Bombay High Court
Donald Trump Declares U.S. Crypto Reserve | Bitcoin, XRP, Solana Soar! 3:05 Donald Trump Declares U.S. Crypto Reserve | Bitcoin, XRP, Solana Soar!
Buy The Dip Or Sell The Market? Where To Deploy Fresh Money? Bullet Proof Your Portfolio 31:54 Buy The Dip Or Sell The Market? Where To Deploy Fresh Money? Bullet Proof Your Portfolio
belgium india 1:41 EAM S Jaishankar Highlights India’s Growing Tech, Trade Ties With Belgium
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Oct 25, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 302621
  • Average Price ₹397.90
Oct 25, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 302621
  • Average Price ₹397.90
Oct 25, 2022 PURCHASE
ISHARES MSCI INDIA SMALL-CAP ETF
  • Qty 39265
  • Average Price ₹397.90
Oct 25, 2022 Sell
ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 39265
  • Average Price ₹397.90
Oct 17, 2022 PURCHASE
ISHARES MSCI INDIA SMALL-CAP ETF
  • Qty 39226
  • Average Price ₹390.85
Oct 17, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 302331
  • Average Price ₹390.85
Oct 17, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 302331
  • Average Price ₹390.85
Oct 17, 2022 Sell
ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 39226
  • Average Price ₹390.85
Oct 11, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 294302
  • Average Price ₹393.10
Oct 11, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 294302
  • Average Price ₹393.10
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jun 24, 2020 PURCHASE
CENTILLION RESEARCH INDIA LLP
  • Qty 1502024
  • Average Price ₹465.46
Jun 24, 2020 Sell
CENTILLION RESEARCH INDIA LLP
  • Qty 1502024
  • Average Price ₹465.63
Jun 23, 2020 PURCHASE
CENTILLION RESEARCH INDIA LLP
  • Qty 2431725
  • Average Price ₹494.59
Jun 23, 2020 PURCHASE
HRTI PRIVATE LIMITED
  • Qty 1905536
  • Average Price ₹498.19
Jun 23, 2020 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 2166286
  • Average Price ₹492.61
Jun 23, 2020 PURCHASE
SHADOWFAX ADVERTISERS PRIVATE LIMITED
  • Qty 3449645
  • Average Price ₹500.63
Jun 23, 2020 PURCHASE
SURJECTIVE RESEARCH CAPITAL LLP
  • Qty 2720020
  • Average Price ₹495.64
Jun 23, 2020 PURCHASE
ALPHAGREP SECURITIES PRIVATE LIMITED
  • Qty 2918705
  • Average Price ₹499.24
Jun 23, 2020 Sell
ALPHAGREP SECURITIES PRIVATE LIMITED
  • Qty 2918705
  • Average Price ₹499.41
Jun 23, 2020 Sell
CENTILLION RESEARCH INDIA LLP
  • Qty 2431725
  • Average Price ₹494.80
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Glenmark Pharmaceuticals Ltd share price previously?
Glenmark Pharmaceuticals Ltd share price was up by 2.68% from the previous closing price of ₹1,278.95.
Who are peers of Glenmark Pharmaceuticals Ltd?
The peers of Glenmark Pharmaceuticals Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Glenmark Pharmaceuticals Ltd?
The promotor/promotors of Glenmark Pharmaceuticals Ltd are Glenn Saldanha, Cheryl Pinto, V S Mani, B E Saldanha, Rajesh Desai., Sona Saira Ramasastry, Dipankar Bhattacharjee, V R Iyer, Pradeep Kumar Sinha.
What has been 52-week high of Glenmark Pharmaceuticals Ltd stocks?
The highest price of Glenmark Pharmaceuticals Ltd stock is ₹1,830.95 in the last 52-week.
What is the share price of Glenmark Pharmaceuticals Ltd (GLENMARK) today on NSE?
As on Mar 03, 2025, Glenmark Pharmaceuticals Ltd (GLENMARK)’s share price on NSE is Rs 1313.2
What is the market cap of Glenmark Pharmaceuticals Ltd (GLENMARK?)
The current market capitalisation of Glenmark Pharmaceuticals Ltd (GLENMARK) is 36,090.45 crores
What is Glenmark Pharmaceuticals Ltd Share symbol?
The symbol of Glenmark Pharmaceuticals Ltd is GLENMARK.
What is the PE ratio of Glenmark Pharmaceuticals Ltd (GLENMARK)?
The current PE ratio of Glenmark Pharmaceuticals Ltd (GLENMARK) is -205.26.
What is the PB ratio of Glenmark Pharmaceuticals Ltd (GLENMARK)?
The current PB ratio of Glenmark Pharmaceuticals Ltd (GLENMARK) is 4.27.
Today’s High & Low share prices of Glenmark Pharmaceuticals Ltd (GLENMARK) on NSE?
Today, the share price of Glenmark Pharmaceuticals Ltd (GLENMARK) on NSE touched a high of Rs 1318.75 and a low of Rs 1277.3
What price did Glenmark Pharmaceuticals Ltd (GLENMARK) shares open on the NSE today?
On NSE, the share price of Glenmark Pharmaceuticals Ltd (GLENMARK) opened at Rs 1278
What is the 52-week high of Glenmark Pharmaceuticals Ltd (GLENMARK)?
The 52-week high price of Glenmark Pharmaceuticals Ltd (GLENMARK) is Rs 1830.95
What is the 52-week low of Glenmark Pharmaceuticals Ltd (GLENMARK) ?
The 52-week low price of Glenmark Pharmaceuticals Ltd (GLENMARK) is Rs 883

ABOUT GLENMARK PHARMA.

Glenmark Pharmaceuticals Ltd, incorporated in the year 1977, has its registered office in B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026, 91-22-40189999, 91-22-40189986. The main industry in which Glenmark Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Glenmark Pharmaceuticals Ltd is/are Suresh Surana & Associates LLP. In the main management, Glenn Saldanha is chairman and is the company secretary for Glenmark Pharmaceuticals Ltd.

  • GS Glenn Saldanha Chairman & Managing Director
  • CP Cheryl Pinto Executive Director (Corporate)
  • VSM V S Mani Executive Director & Group CFO
  • BES B E Saldanha Non Executive Director
  • RD Rajesh Desai. Independent Non Exe. Director
  • SSR Sona Saira Ramasastry Independent Non Exe. Director
  • DB Dipankar Bhattacharjee Independent Non Exe. Director
  • VRI V R Iyer Independent Non Exe. Director
  • PKS Pradeep Kumar Sinha Additional Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement